Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

NSE/ACCPL stock hub

NSE/ACCPL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/ACCPLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/ACCPL

In the news

Latest news · NSE/ACCPL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E13

P25 n/aP50 n/aP75 n/a

ROE27.6

P25 n/aP50 n/aP75 n/a

ROIC16.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/ACCPL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

167

Groups with data

Currency

INR

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	125
Enterprise value	INR 1.4B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 1.3B
Price	INR 118
Price currency	INR
Rev Per Employee	7,185,408x
Sic	2834
Symbol	nse/ACCPL
Website	https://www.accretionpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.39%
EV Earnings	14.4x
EV/EBIT	9.99x
EV/EBITDA	9.19x
EV/FCF	-6.01x
EV/Sales	1.55x
FCF yield	-17.69%
P/B ratio	2.39x
P/E ratio	13.04x
P/S ratio	1.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.51%
EBITDA Margin	16.86%
Gross margin	27.46%
Gross Profit	INR 246.6M
Gross Profit Growth	42.12%
Gross Profit Growth Q	44.77%
Net Income	INR 96.7M
Net Income Growth	42.31%
Net Income Growth Q	57.74%
Pretax Margin	14.57%
Profit Margin	10.76%
Profit Per Employee	INR 773,400
ROA	14.94
ROCE	24.95
ROE	27.62
ROIC	16.34
Roic5y	16.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	6.54
EPS Growth Q	16.68
OCF Growth Q	-92.53%
Revenue Growth	56.54x
Revenue Growth Q	5.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 1.54
Assets	INR 766.6M
Cash	INR 40.2M
Current Assets	INR 605.9M
Current Liabilities	INR 208.1M
Debt	INR 123.2M
Debt EBITDA	INR 0.81
Debt Equity	INR 0.23
Debt FCF	INR -0.53
Equity	INR 547.1M
Interest Coverage	16.43
Liabilities	INR 219.5M
Long Term Assets	INR 160.6M
Long Term Liabilities	INR 11.3M
Net Cash	INR -83M
Net Cash By Market Cap	INR -6.34
Net Debt EBITDA	INR 0.55
Net Debt Equity	INR 0.15
Tangible Book Value	INR 547.1M
Tangible Book Value Per Share	INR 49.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.91
Inventory Turnover	2.66
Net Working Capital	INR 472.2M
Quick ratio	1.27
Working Capital	INR 397.8M
Working Capital Turnover	INR 3.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-33.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	71.22
50-day SMA	78.4
50-day SMA vs 200-day SMA	50over200
All Time High	118.1
All Time High Change	-0.3%
All Time High Date	2026-05-08
All Time Low	53.8
All Time Low Change	118.87%
All Time Low Date	2025-10-14
ATR	5.07
Beta1y	0.55
Ch YTD	34.04
High	118.1
High52	118.1
High52 Date	2026-05-08
High52ch	-0.3%
Low	110
Low52	53.8
Low52 Date	2025-10-14
Low52ch	118.87%
Ma50ch	50.2%
Price vs 200-day SMA	65.34%
RSI	78.46
RSI Monthly	0
RSI Weekly	75.59
Sharpe ratio	0.86x
Sortino ratio	1.62
Total Return	-33.57%
Tr YTD	34.04
Tr1m	52.63%
Tr1w	3.24%
Tr3m	76.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 139.3M
Operating Income Growth	25.17
Operating Income Growth Q	30.31
Operating margin	15.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,946,000%
Net Borrowing	-17,824,000
Shares Insiders	73.5%
Shares Out	11,116,000
Shares Qo Q	0%
Shares Yo Y	33.57%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -231.5M
Average Volume	51,420x
Bv Per Share	49.27
CAPEX	INR -85.3M
Ch1m	52.63
Ch1w	3.24
Ch3m	76.8
Ch6m	105.9
Change	4.67%
Change From Open	5.94
Close	112.5
Days Gap	-1.2
Depreciation Amortization	12,111,000
Dollar Volume	4,945,500
Earnings Date	2026-05-08
EBIT	INR 139.3M
EBITDA	INR 151.4M
EPS	INR 9.03
F Score	4
FCF	INR -231.5M
FCF EV Yield	-16.64x
FCF Per Share	INR -20.83
Financing CF	271,244,000
Fiscal Year End	March
Founded	2,012
Graham Number	100.05357
Graham Upside	-15.03
Income Tax	INR 34.2M
Investing CF	-85,338,000
Is Primary Listing	1
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Ma150	74.24
Ma150ch	58.61%
Ma20	94.3
Ma20ch	24.86%
Net CF	39,698,000
Next Earnings Date	2026-06-10
Open	111.2
Position In Range	95.68
Ppne	134,137,000
Price Date	2026-05-08
Price EBITDA	INR 8.64
Ptbv Ratio	2.39
Relative Volume	0.82x
Revenue	898,176,000x
Tax By Revenue	3.8x
Tax Rate	26.11%
Tr6m	105.86%
Volume	42,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/ACCPL pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns NSE/ACCPL?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+73.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+33.6%

Negative means the company is buying back shares.

Technical

NSE/ACCPL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

78.5

Above 70: short-term overbought

Price vs 200-day MA

+65.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.86

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/ACCPL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/ACCPL stock rating?

nse/ACCPL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/ACCPL analysis?

The full report lives at /stocks/nse/ACCPL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/ACCPL?

The latest report frames nse/ACCPL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/ACCPL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.